Human CXCL9 ELISA Kit
search
  • Human CXCL9 ELISA Kit

Human CXCL9 ELISA Kit

Catalog # FM-E100188

Print

$649.00
Quantity

For research use only. Not for diagnostic or therapeutic use, or for human or veterinary use. Sold only to research institutions and qualified laboratory professionals. Not for sale to individuals for personal use.

Assay Range

31.2-2,000 pg/mL  

Sensitivity

2.0 pg/mL

Specificity

No cross-reaction with other related substances detected

Size

96T

Storage

Store at 2 - 8ºC. Keep reconstituted standard and detection Ab at -20 ºC

Assay Principle

Sandwich ELISA

Sample Volume

100 µL final volume, dilution factor varies on samples

Detection Method

Chromogenic

 

 

Kit Components

 

 1. Recombinant Human CXCL9  standard: 2 vials

 2. One 96-well plate coated with Human CXCL9  Ab

 3. Sample diluent buffer: 12 mL - 1

 4. Detection antibody: 130 µL, dilution 1:100

 5. Streptavidin-HRP: 130 µL, dilution 1:100

 6. Antibody diluent buffer: 12 mL x1   

 7. Streptavidin-HRP diluent buffer: 12 mL x1

 8. TMB developing agent: 10 mL x1

 9. Stop solution: 10 mL x1

10. Washing solution (20x): 25 mL x1

 

 

Background

 

CXCL9, also known as Monokine Induced by Gamma Interferon (MIG), Gamma-interferon- induced monokine, Small-inducible cytokine B9, is a small cytokine belonging to the CXC chemokine family. CXCL9 is synthesized as a 125 amino acid (aa) precursor protein with a 22 aa signal sequence and a 103 aa mature protein. It is closely related to two other CXC chemokines CXCL10 and CXCL11 which lack an ELR (Glu-Leu-Arg) motif in front of the first cysteine. It is reported that ELR+ CXC chemokines attract neutrophils and promote angiogenesis via chemokine receptors CXCR1 and CXCR2, ELR- CXC chemokines including CXCL9 recruit activated lymphocytes and retard angiogenesis via the chemokine receptor CXCR3. Expression of MIG is induced by IFN-γ in a variety of cells and tissues, including monocytes/macrophages, neutrophils, keratinocytes, endothelial cells, epithelial cells, astrocytes, thyrocytes, liver, and kidney. IFN-γ-dependent production of CXCL9 by endothelial cells is inhibited by nitric oxide (NO) donors such as sodium nitroprusside and peroxisome proliferator-activated receptor-γ activators such as 15-deoxy-PGJ2, and lysophosphatidylcholine. These observations have been implicated in the pathogenesis of certain related diseases. In mouse models, CXCL9 is important in anti-viral host defense and can induce T cell-dependent tumor regression.

New